Refractory Adult Acute Lymphoblastic Leukemia

Explore clinical trials studying Refractory Adult Acute Lymphoblastic Leukemia. Study availability and eligibility vary by location and protocol.

4 public trials 2 recruiting studies

Refine in advanced search Browse all conditions

Refractory Adult Acute Lymphoblastic Leukemia trial results

Recruiting

NCT02727803

Conditions: Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Acute Biphenotypic Leukemia, Acute Lymphoblastic Leukemia, +55 more
Locations: M D Anderson Cancer Center Houston, Texas, United States

Recruiting

NCT03326921

Conditions: Acute Biphenotypic Leukemia, Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, +63 more
Locations: Fred Hutch/University of Washington Cancer Consortium Seattle, Washington, United States

Completed

NCT02484430

Conditions: B Acute Lymphoblastic Leukemia, B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1, B Acute Lymphoblastic Leukemia, Philadelphia Chromosome Negative, +25 more
Locations: Mayo Clinic Hospital in Arizona Phoenix, Arizona, United States

Mayo Clinic in Arizona Scottsdale, Arizona, United States

City of Hope Comprehensive Cancer Center Duarte, California, United States

Los Angeles General Medical Center Los Angeles, California, United States

View all 14 locations

Completed

NCT01858740

Conditions: Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Acute Biphenotypic Leukemia, Acute Leukemia of Ambiguous Lineage, +41 more
Locations: Fred Hutch/University of Washington Cancer Consortium Seattle, Washington, United States